Arca
Skip to content

Endoscopic Linear Cutting Staplers and Loading Units for Single Use

Staple, Implantable. 510(k) K181620, from Ezisurg (Suzhou) Medical Co., Ltd. (Suzhou, CN). Product code GDW, class 2.

As of Nov 17, 2026, K181620 is an FDA 510(k) held by Ezisurg (Suzhou) Medical Co., Ltd., substantially equivalent on Sep 18, 2018 after 90 days, with no recalls tied to it in FDA's recall database.

  • Substantially equivalent: Sep 18, 2018
  • Review time: 90 days
  • Recalls: 0

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

The device is intended for transection, resection, and/or creation of anastomoses. The instruments have application in multiple open or minimally invasive general abdominal, gynecologic, thoracic, and pediatric surgical procedures.

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Other GDW Clearances

The newest 510(k)s for the same product code; their median review was 132 days; see every GDW device

Record

Type
Traditional
Received
Jun 20, 2018
Review panel
General, Plastic Surgery
Regulation
21 CFR 878.4750

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.